Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital

por Blairon, Laurent, Wilmet, Alain, Beukinga, Ingrid, Tré-Hardy, Marie
Publicado 2020

Clinical evaluation of the GSD NovaPrime® SARS-CoV-2 RTq-PCR assay

por Tré-Hardy, Marie, Piteüs, Sébastien, Beukinga, Ingrid, Blairon, Laurent
Publicado 2022

Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcar...

por Tré-Hardy, Marie, Cupaiolo, Roberto, Wilmet, Alain, Beukinga, Ingrid, Blairon, Laurent
Publicado 2021

The challenge of screening SARS-CoV-2 variants of concern with RT-qPCR: One variant can hide another

por Blairon, Laurent, Cupaiolo, Roberto, Piteüs, Sébastien, Beukinga, Ingrid, Tré-Hardy, Marie
Publicado 2021

Circulating (CD3(−)CD19(+)CD20(−)IgD(−)CD27(high)CD38(high)) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy?

por Pozdzik, Agnieszka, Beukinga, Ingrid, Gu-Trantien, Chunyan, Willard-Gallo, Karen, Nortier, Joëlle, Pradier, Olivier
Publicado 2016

Enterococcus thailandicus, an unusual pathogen in humans encountered in an intra-abdominal infection

por Mbouche, Patricia, Blairon, Laurent, Cupaiolo, Roberto, Zaouak, Yasmine, Hainaux, Bernard, Beukinga, Ingrid, Tré-Hardy, Marie
Publicado 2023

The role of serology for COVID-19 control: Population, kinetics and test performance do matter

por Tré-Hardy, Marie, Blairon, Laurent, Wilmet, Alain, Beukinga, Ingrid, Malonne, Hugues, Dogné, Jean-Michel, Douxfils, Jonathan
Publicado 2020

Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak

por Blairon, Laurent, Mokrane, Saphia, Wilmet, Alain, Dessilly, Géraldine, Kabamba-Mukadi, Benoît, Beukinga, Ingrid, Tré-Hardy, Marie
Publicado 2021

Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers

por Tré-Hardy, Marie, Cupaiolo, Roberto, Papleux, Emmanuelle, Wilmet, Alain, Horeanga, Alexandra, Antoine-Moussiaux, Thomas, Della Vecchia, Andrea, Beukinga, Ingrid, Vekemans, Marc, Blairon, Laurent
Publicado 2021

Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary

por Tré-Hardy, Marie, Cupaiolo, Roberto, Wilmet, Alain, Antoine-Moussiaux, Thomas, Della Vecchia, Andrea, Horeanga, Alexandra, Papleux, Emmanuelle, Vekemans, Marc, Beukinga, Ingrid, Blairon, Laurent
Publicado 2021

Assessment 2 months after the administration of a 3rd dose mRNA: a new variant-adapted vaccine is expected

por Tré-Hardy, Marie, Cupaiolo, Roberto, Wilmet, Alain, Antoine-Moussiaux, Thomas, Coman-Vlagea, Nicoleta, Della Vecchia, Andrea, Horeanga, Alexandra, Papleux, Emmanuelle, Vekemans, Marc, Beukinga, Ingrid, Blairon, Laurent
Publicado 2022